A hospital-based HTA model to assess the economic and organizational impact of intravenous-to-subcutaneous monoclonal antibody transitions in oncology

Giorgia Zorzetto, Alberto Russi, Alessandro Giuriola, Giuseppe Di Blasio, Sara Lonardi, Valentina Guarneri, Marco Maruzzo, Maria Vittoria Dieci, Giulia Pasello, Michele Gottardi, Silvia Cognolato, Nicoletta Rigamonti, Chiara Mioni, Flavio Cazzador, Giulia Badaile, Francesca Pipitone, Daniela Grosso, Patrizia Simionato, Giovanna Scroccaro, Marina Coppola

Open source

DOI: 10.1017/s0266462326104000
Published: 2026
Container: International Journal of Technology Assessment in Health Care
Publisher: Cambridge University Press (CUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1017/s0266462326104000,
  title = {A hospital-based HTA model to assess the economic and organizational impact of intravenous-to-subcutaneous monoclonal antibody transitions in oncology},
  author = {Giorgia Zorzetto and Alberto Russi and Alessandro Giuriola and Giuseppe Di Blasio and Sara Lonardi and Valentina Guarneri and Marco Maruzzo and Maria Vittoria Dieci and Giulia Pasello and Michele Gottardi and Silvia Cognolato and Nicoletta Rigamonti and Chiara Mioni and Flavio Cazzador and Giulia Badaile and Francesca Pipitone and Daniela Grosso and Patrizia Simionato and Giovanna Scroccaro and Marina Coppola},
  year = {2026},
  journal = {International Journal of Technology Assessment in Health Care},
  doi = {10.1017/s0266462326104000},
  url = {https://doi.org/10.1017/s0266462326104000}
}

RIS

TY  - JOUR
TI  - A hospital-based HTA model to assess the economic and organizational impact of intravenous-to-subcutaneous monoclonal antibody transitions in oncology
AU  - Giorgia Zorzetto
AU  - Alberto Russi
AU  - Alessandro Giuriola
AU  - Giuseppe Di Blasio
AU  - Sara Lonardi
AU  - Valentina Guarneri
AU  - Marco Maruzzo
AU  - Maria Vittoria Dieci
AU  - Giulia Pasello
AU  - Michele Gottardi
AU  - Silvia Cognolato
AU  - Nicoletta Rigamonti
AU  - Chiara Mioni
AU  - Flavio Cazzador
AU  - Giulia Badaile
AU  - Francesca Pipitone
AU  - Daniela Grosso
AU  - Patrizia Simionato
AU  - Giovanna Scroccaro
AU  - Marina Coppola
PY  - 2026
JO  - International Journal of Technology Assessment in Health Care
DO  - 10.1017/s0266462326104000
UR  - https://doi.org/10.1017/s0266462326104000
ER  -

APA

Zorzetto, G., Russi, A., Giuriola, A., Blasio, G. D., Lonardi, S., Guarneri, V., Maruzzo, M., Dieci, M. V., Pasello, G., Gottardi, M., Cognolato, S., Rigamonti, N., Mioni, C., Cazzador, F., Badaile, G., Pipitone, F., Grosso, D., Simionato, P., Scroccaro, G., & Coppola, M. (2026). A hospital-based HTA model to assess the economic and organizational impact of intravenous-to-subcutaneous monoclonal antibody transitions in oncology. International Journal of Technology Assessment in Health Care. https://doi.org/10.1017/s0266462326104000

Source records

crossref · retrieved 2026-09-26T02:25:14.499Z